Treatment OutcomeCisplatinAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsCombined Modality TherapyDoxorubicinEtoposideCyclophosphamideDrug Administration ScheduleLung NeoplasmsDisease-Free SurvivalDrug Resistance, NeoplasmSurvival AnalysisNeoadjuvant TherapyVinblastinePaclitaxelPlatinumNeoplasm StagingCarboplatinSurvival RateDeoxycytidineOvarian NeoplasmsIfosfamideTaxoidsBreast NeoplasmsPrognosisMethotrexateCarcinoma, Non-Small-Cell LungVomitingNeoplasm Recurrence, LocalInduction ChemotherapyBleomycinNeoplasmsTesticular NeoplasmsCell Line, TumorNauseaAntimetabolites, AntineoplasticAdenocarcinomaNeutropeniaCarcinoma, Squamous CellLeukopeniaInfusions, IntravenousHead and Neck NeoplasmsAntineoplastic Agents, PhytogenicCamptothecinDose-Response Relationship, DrugMitomycinAntineoplastic Agents, AlkylatingSalvage TherapyNeoplasms, Germ Cell and EmbryonalFollow-Up StudiesNeoplasm MetastasisStomach NeoplasmsTegafurApoptosisRadiotherapy, AdjuvantDrug Screening Assays, AntitumorTime FactorsVindesineAntiemeticsCytarabineChemotherapy, Cancer, Regional PerfusionGerminomaOrganoplatinum CompoundsAnthracyclinesPlatinum CompoundsDrug SynergismCarmustineOxonic AcidOsteosarcomaDNA AdductsRadiotherapyInfusions, Intra-ArterialDacarbazineAntibiotics, AntineoplasticKaplan-Meier EstimateCarcinomaGranulocyte Colony-Stimulating FactorFluorouracilProspective StudiesPeritoneal NeoplasmsTransplantation, AutologousRadiotherapy DosageThrombocytopeniaBone NeoplasmsTumor Cells, CulturedClinical Trials as TopicLymphoma, Non-HodgkinLiver NeoplasmsHodgkin DiseaseCell SurvivalBrain NeoplasmsColorectal NeoplasmsLomustineMelphalanDrug EvaluationEsophageal NeoplasmsDisease ProgressionMesothelioma